Figure 5. Effect of isorhamnetin obtained by echocardiographic
findings.
(A) Representative echocardiographic images from B-Mode. (B)
Quantification of LAD (control, n = 5; AngII, n = 5; AngII+isorhamnetin,
n = 5). (C) Quantification of AW/BW (control, n = 6; AngII, n = 6;
AngII+isorhamnetin, n = 6). (D) Quantification of levels of Nppb .
qRT-PCR analysis of mRNA levels normalized with 18 s (control, n = 6;
AngII, n = 6; AngII+isorhamnetin, n = 6). **P < 0.01
control vs. AngII; *P < 0.05 control vs. AngII by
one-way ANOVA with post-hoc test (Tukey);##P < 0.01 AngII vs.
AngII+isorhamnetin; #P < 0.05 AngII
vs. AngII+isorhamnetin by one-way ANOVA with post-hoc test
(Tukey).